Providing clean, pure air for a healthier, more sustainable world.

450 employees, 4 production plants, a dozen sales subsidiaries, including 8 in Europe, 36 million masks, 1.8 million filters and sales of 55 million euros by 2021: that’s Deltrian’s identity card.

Concerned that 7 million people die every year from inhaling foul air, Europe’s sixth-largest player in the market supplies filters to eliminate airborne particles. Products but also services: Deltrian offers maintenance for air handling units installed on the roofs or in the technical rooms of industrial buildings, offices and car manufacturers. The maintenance and timely replacement of filters are essential to ensure both a reduction in energy consumption and an improvement in air quality.

In March 2020, Deltrian began producing surgical masks in partnership with the Walloon government: in two months, the company acquired machinery and raw materials and produced the first masks in June. An industrial record to beat! But the tight deadline is not its only success: in addition to citizens’ masks and medical silicone masks for dusty environments, Deltrian produces virucidal surgical masks, a valuable solution for reducing the spread of nosocomial diseases in hospitals. Its secret weapon? Cold plasma technology, which enables citric acid to be deposited on the outer layer of the mask, deactivating viruses on contact.
This technology has been transposed to the production of the very first virus-deactivating air filters: distributed under the name Deltri+ Technology and boasting energy labels of up to A+. This new type of filter can replace any bag filter in any existing installation, while adding extra protection against viruses. A real breakthrough in the world of filtration.

Other innovations are being developed to find alternative solutions to the use of fibreglass, polypropylene and polyethylene in filter manufacture. These are major projects that will ultimately strengthen Deltrian’s competitive advantages and sustainable objectives.
Today, the company has no shortage of ambition: it is aiming for sales of €100 million in 2026 and intends to become one of the world leaders in filtration. In the meantime, Deltrian will continue to develop ever more innovative masks and filters, exploring the countless operating possibilities offered by cold plasma technology to meet market needs. All these possibilities will help Deltrian to realise its vision of a healthier and more sustainable world.

Read the article here: https://www.belgian-research.eu/